Newly proposed fibrosis staging criterion for assessing carbon tetrachloride- and albumin complex-induced liver fibrosis in rodents

Pathology International

Volumn 58, Issue 9, 2008, Pages 580-588

  Zhao, Xin Yan ^a   Wang, Bao En ^a   Li, Xin Min ^a   Wang, Tai Ling ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

Albumin complex; Carbon tetrachloride; Computer assisted image analysis; Experimental liver cirrhosis; Fibrosis stage; Histological activity index

Indexed keywords

ALBUMIN; CARBON TETRACHLORIDE; HYDROXYPROLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CONTROLLED STUDY; CYTOARCHITECTURE; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE SEVERITY; EXPERIMENTAL MODEL; FEMALE; HISTOPATHOLOGY; IMAGE ANALYSIS; KNODELL STAGING; LIVER FIBROSIS; MALE; MOUSE; NONHUMAN; OBSERVER VARIATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REPRODUCIBILITY; SCORING SYSTEM; SPECIES DIFFERENCE; STATISTICAL SIGNIFICANCE; VIRUS HEPATITIS;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; CARBON TETRACHLORIDE; HUMANS; HYDROXYPROLINE; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; MICE; MICE, INBRED BALB C; OBSERVER VARIATION; RATS; RATS, WISTAR; REPRODUCIBILITY OF RESULTS; SERUM ALBUMIN;

EID: 49749084758     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2008.02274.x     Document Type: Article

References (39)

1. Horani A, Muhanna N, Pappo O et al. Beneficial effect of glatiramer acetate (Copaxone) on immune modulation of experimental hepatic fibrosis. Am J Physiol Gastrointest Liver Physiol 2007 292 : G628 38.
2. Hsu YC, Lin YL, Chiu YT, Shiao MS, Lee CY, Huang YT. Antifibrotic effects of Salvia miltiorrhiza on dimethylnitrosamine intoxicated rats. J Biomed Sci 2005 12 : 185 95.
3. Assy N, Hussein O, Khalil A et al. The beneficial effect of aspirin and enoxaparin on fibrosis progression and regenerative activity in a rat model of cirrhosis. Dig Dis Sci 2007 52 : 1187 93.
4. Yeh TS, Ho YP, Huang SF, Yeh JN, Jan YY, Chen MF. Thalidomide salvages lethal hepatic necroinflammation and accelerates recovery from cirrhosis in rats. J Hepatol 2004 41 : 606 12.
5. Huang YH, Shi MN, Zheng WD, Zhang LJ, Chen ZX, Wang XZ. Therapeutic effect of interleukin-10 on CCl4-induced hepatic fibrosis in rats. World J Gastroenterol 2006 12 : 1386 91.
6. Liu SQ, Yu JP, Chen HL, Luo HS, Chen SM, Yu HG. Therapeutic effects and molecular mechanisms of Ginkgo biloba extract on liver fibrosis in rats. Am J Chin Med 2006 34 : 99 114.
7. Kang KW, Choi SH, Ha JR, Kim CW, Kim SG. Inhibition of dimethylnitrosamine-induced liver fibrosis by [5-(2-pyrazinyl)-4-methyl-1,2- dithiol-3-thione] (oltipraz) in rats: Suppression of transforming growth factor-beta1 and tumor necrosis factor-alpha expression. Chem Biol Interact 2002 139 : 61 77.
8. Thirunavukkarasu C, Yang Y, Subbotin VM, Harvey SA, Fung J, Gandhi CR. Endothelin receptor antagonist TAK-044 arrests and reverses the development of carbon tetrachloride induced cirrhosis in rats. Gut 2004 53 : 1010 19.
9. Roderfeld M, Weiskirchen R, Wagner S et al. Inhibition of hepatic fibrogenesis by matrix metalloproteinase-9 mutants in mice. FASEB J 2006 20 : 444 54.
10. Wang BE, Jia JD. Treatment of liver fibrosis. In : Lam SK, Paumgartner G, Wang BE, eds. Update on Hepatobiliary Disease 1996. Lancaster : Kluwer Academic, 1996 193 211.
11. Constandinou C, Henderson N, Iredale JP. Modeling liver fibrosis in rodents. Methods Mol Med 2005 117 : 237 50.
12. Paronetto F, Popper H. Aggravation of hepatic lesions in mice by in vivo localization of immune complexes (Auer hepatitis). Am J Pathol 1965 47 : 549 63.
13. Wang BE, Wang ZF, Yin WY, Huang SF, Li JJ. Study on experimental immunity model of hepatic fibrosis Zhonghua Yixue Zazhi 1998 69 : 503 5 (in Chinese).
14. Sun MA, Wang BE, Annoni G, Degli Esposti S, Biempica L, Zern MA. Two rat models of hepatic fibrosis. A morphologic and molecular comparison. Lab Invest 1990 63 : 467 75.
15. Reddy GK, Enwemeka CS. A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem 1996 29 : 225 9.
16. Arima M, Terao H, Kashima K, Arita T, Nasu M, Nishizono A. Regression of liver fibrosis in cases of chronic liver disease type C: Quantitative evaluation by using computed image analysis. Intern Med 2004 43 : 902 10.
17. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960 20 : 37 46.
18. Zhu JX, Wang BE, Wang TL. Study on the therapeutic effect of Cordyceps mycelium on experimental hepatic fibrosis of rat Zhong Hua Xiao Hua Zha Zhi 1994 14 : 333 5 (in Chinese).
19. Ma H, Wang BE, Chen YJ, Ma XM. The therapeutic effect of Astragalus membranaceus on liver fibrosis induced by injury in rats Zhong Hua Gang Zhang Bing Za Zhi 1997 7 : 32 5 (in Chinese).
20. Jia JD, Wang BE, Dong Z. The effect of herbal compound 861 on mRNA levels for type I, III and IV collagens and TGF β in immune complex rat liver fibrosis Zhong Hua Gang Zhang Bing Za Zhi 1996 4 : 214 16 (in Chinese).
21. Wang BE, Wang TL, Jia JD. Experimental and clinical study on inhibition and reversion of liver fibrosis with integrated Chinese and Western Medicine. Zhong Guo Zhong Xi Yi Jie He Zha Zhi 1999 5 : 6 11 (in English).
22. Zhao XY, Wang BE, Wang TL. Comparative study of effect of two different herbal compound on CCL4 induced liver fibrosis in rats Lin Chuang Gan Dan Bing Za Zhi 2005 12 : 21 34 (in Chinese).
23. Zhao XY, Wang BE, Wang TL, Li XM. Inhibitory effects of silymarin on hepatic fibrosis induced by dimethylnitrosamine: Experiment with rats Zhonghua Yi Xue Za Zhi 2006 86 : 2563 6 (in Chinese).
24. Zhu YK, Dan ZhP, Wang TE et al Experimental study on effects of QiShen YiQi dropping pills on liver fibrosis in rats Zhong Guo Zhong Xi Yi Jie He Za Zhi 2007 27 : 223 6 (in Chinese).
25. Knodell RG, Ishak KG, Black WC et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981 1 : 431 5.
26. Ludwig J. The nomenclature of chronic active hepatitis: An obituary. Gastroenterology 1993 105 : 274 8.
27. Scheuer PJ. Classification of chronic viral hepatitis: A need for reassessment. J Hepatol 1991 13 : 372 4.
28. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994 20 : 15 20.
29. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996 24 : 289 93.
30. Ishak K, Baptista A, Bianchi L et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995 22 : 696 9.
31. Duffield JS, Forbes SJ, Christothea M et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 2005 115 : 56 65.
32. Jiang YC, Kang YJ. Metallothionein gene therapy for chemical-induced liver fibrosis in mice. Mol Ther 2004 10 : 1130 39.
33. Lee HS, Huang GT, Chen CH et al. Less reversal of liver fibrosis after prolonged carbon tetrachloride injection. Hepatogastroenterology 2001 48 : 1312 15.
34. Standish RA, Cholongitas E, Dhillon A, Burroughs AK, Dhillon AP. An appraisal of the histopathological assessment of liver fibrosis. Gut 2006 55 : 569 78.
35. Pilette C, Rousselet MC, Bedossa P et al. Histopathological evaluation of liver fibrosis: Quantitative image analysis vs semi-quantitative scores. Comparison with serum markers. J Hepatol 1998 28 : 439 46.
36. Wright M, Thursz M, Pullen R, Thomas H, Goldin R. Quantitative versus morphological assessment of liver fibrosis: Semi-quantitative scores are more robust than digital image fibrosis area estimation. Liver Int 2003 23 : 28 34.
37. Ratziu V, Charlotte F, Heurtier A et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005 128 : 1898 906.
38. Regev A, Berho M, Jeffers LJ et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002 97 : 2614 18.
39. Lee HS, Shun CT, Chiou LL, Chen CH, Huang GT, Sheu JC. Hydroxyproline content of needle biopsies as an objective measure of liver fibrosis: Emphasis on sampling variability. J Gastroenterol Hepatol 2005 20 : 1109 14.